"Chinese scientists identify drug that reduces risk of severe pneumonia during Covid-19 infection — Only 6.3 percent of the hypertensive patients who were given angiotensin-converting enzyme inhibitors, or angiotensin-receptor blockers (ACEI/ARB), suffered from a pneumonia complication while infected by the coronavirus, according to their data..."